Advestra has acted as Swiss legal counsel to the initial purchasers and lenders in connection with the financing of Bain Capital’s acquisition of SO.MA.CI.S. and the subsequent acquisition of AT&
Tags :Advestra
Advestra advised OEP 80, an indirect subsidiary of OEP VIII, on its publishing of a mandatory public tender offer for all publicly held shares of Cicor Tech
Baker McKenzie Switzerland advised R&S Group, a manufacturer of electrical infrastructure, in connection with its new CHF 160 million term loan (TL) and CHF 30 million revolving credit facilities (RCF) agreement with UBS Switzerland, advised
Advestra advised LPSO Holding (LPSO), the primary holding company of the Sawiris family, the majority shareholder group of ODH, on a voluntary public tender offer
Advestra advised Zürcher Kantonalbank as agent, security agent and lender and the other syndicate banks as lenders on the CHF 155 million syndicated cred
Advestra has advised SGS, an inspection, verification, testing, and certification company, on its acquisition of CertX, a certification specialist in cybersecurity, artificial intel
Advestra has advised Viseca Payment Services in the placemento of CHF 150 million of 1.350% senior bonds, due 2029. The placement was supported by Raiffeisen Schweiz Genossenschaft, UBS, and Zürcher Kantonalbank,
Advestra acted as Swiss legal counsel to Novartis, which successfully placed notes in the aggregate principal amount of USD 3.7 billion in four tranches of USD 1 billion 3.800%
Advestra advised eMolecules and Avista Healthcare Partners (of which eMolecules is a porfolio company), on the acquisition of all shares in Synple Chem. The acquisition strategically expands eMolecules’ product and service portfolio to
A group of investors led by Verium, a multi-family office advised by Advestra, has acquired a significant minority stake in Lynus through a capital increase. Lynus is